State of the Union: Frequently Asked Questions, and More from CRS
Noteworthy new and updated reports from the Congressional Research Service include the following.
History, Evolution, and Practices of the President’s State of the Union Address: Frequently Asked Questions, updated January 29, 2020
The United Nations Framework Convention on Climate Change, the Kyoto Protocol, and the Paris Agreement: A Summary, January 29, 2020
The Washington Post’s “Afghanistan Papers” and U.S. Policy: Main Points and Possible Questions for Congress, January 28, 2020
Solar Energy: Frequently Asked Questions, January 27, 2020
Challenges to the United States in Space, CRS In Focus, updated January 27, 2020
Instances of Use of United States Armed Forces Abroad, 1798-2020, updated January 13, 2020
National Emergency Powers, updated December 5, 2019
Diplomacy with North Korea: A Status Report, CRS In Focus, January 22, 2020
The U.S. Nuclear Weapons Complex: Overview of Department of Energy Sites, updated February 3, 2020
Presidential Pardons: Overview and Selected Legal Issues, January 14, 2020
Congressional Oversight Manual, updated January 16, 2020
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.